Janjigian, Y. Y. Et Al. 2024. Pembrolizumab in HER2-Positive Gastric Cancer. NEW ENGLAND JOURNAL OF MEDICINE .

Janjigian, Y. Y., Kawazoe, A., Bai, Y., Xu, J., Lonardi, S., Metges, J. P., ... Yanez, P.(2024). Pembrolizumab in HER2-Positive Gastric Cancer. NEW ENGLAND JOURNAL OF MEDICINE .

Janjigian, Yelena Et Al. "Pembrolizumab in HER2-Positive Gastric Cancer," NEW ENGLAND JOURNAL OF MEDICINE , 2024

Janjigian, Yelena Y. Et Al. "Pembrolizumab in HER2-Positive Gastric Cancer." NEW ENGLAND JOURNAL OF MEDICINE , 2024

Janjigian, Y. Y. Et Al. (2024) . "Pembrolizumab in HER2-Positive Gastric Cancer." NEW ENGLAND JOURNAL OF MEDICINE .

@article{article, author={Yelena Y. Janjigian Et Al. }, title={Pembrolizumab in HER2-Positive Gastric Cancer}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2024}